The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA's capacity to determine disability benefits more quickly and efficiently using the Listings.

Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions. With the development of potential new treatments, it is crucial for cardiac physicians to be well informed on the pathophysiology, assessment, treatment options and their outcomes of valvular diseases. Written by a highly experienced and internationally recognized group of cardiologists, cardiac surgeons, and researchers, Valvular Heart Disease offers insights into the widely varying hemodynamic effects and clinical course of heart valve conditions, as well as the contemporary management of these conditions. Offering a broad perspective on these diseases, Valvular Heart Disease expands on the recent guidelines developed by the major heart societies in the United State and Europe.

This book provides a state-of-the-art description of the pathophysiology, diagnosis and management of valvular heart disease (VHD). With an aging population, the incidence and complexity of VHD has markedly increased and the introduction of transcatheter valve therapies have revolutionized the management of these frequent and serious cardiovascular diseases. The development of percutaneous valve interventions has revolutionized the management of VHD (or has dramatically changed its management) Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.

This book serves as the "go-to" resource for cardiovascular nurses and other health care practitioners involved in the care of patients with acquired valvular heart disease. It includes unique information about heart valve anatomy and pathophysiology, the complexity of clinical presentations and diagnostic evaluation, patient education and shared decision-making, surgical and transcatheter treatment options, and transition to palliative care. The content focuses primarily on the specialized care of patients with aortic stenosis and regurgitation, and mitral and tricuspid regurgitation. In addition, this unique resource provides timely information to guide a patient-centred and team-driven approach that reflects contemporary and innovative practice in the management of valvular heart disease. The essential topics of strengthening the multidisciplinary Heart Team and programmatic processes of care, the priorities for nursing care, and the multifactorial challenges of managing this complex patient population are explored in detail. Importantly, this resource aims to support all clinicians who are involved in the various timepoints of patients' full trajectory of care, from their evaluation pathway, admissions for treatment, and long term follow-up. Clinicians require contemporary knowledge and evidence to guide their practice, provide appropriate care for this complex patient population, and contribute to the advancement of practice. To date, there has been little emphasis placed on the management of valvular heart disease in cardiovascular nursing and allied health curriculum. This book fills this gap and addresses the pressing need for a user-friendly resource to guide the care for this growing population in a rapidly changing clinical environment. The editors are international leaders in the care and management of patients with acquired valvular heart disease and program development. They are widely recognized for their pioneering role in shaping the way we care for these patients.

The notion that drugs can induce valvular heart disease (VHD) has occurred since the sixties and has received a lot of attention in recent years. Overstimulation of the serotonin 2B receptor (5-HT2B) leads to valvular fibroblast proliferation and thickening of the valvular leaflets with reduced mobility and regurgitation as a consequence. This new book focuses on different aspects of this distinct kind of valvulopathy including pathophysiology of drug-induced VHD, histopathological and echocardiographic characteristics, drugs associated with VHD, the influence of cumulative drug dose and risk factors and others.

Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. International editors and chapter authors ensure a truly global perspective. Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. Consolidates today’s available information and guidance into a single, convenient resource.

Highly-illustrated and in line with current European guidelines, this handbook covers all aspects of the management of patients with valvular heart disease, providing clear advice on pathophysiology, diagnosis, investigation and treatment, including in special situations such as pregnancy or during non-cardiac surgery.